Study Summary
This trial is testing a drug to see if it increases the chances of a successful surgery to remove a pancreatic tumor, as well as if it is safe and well tolerated.
- Pancreatic Cancer
Treatment Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 36 months
Trial Safety
Trial Design
1 Treatment Group
Bethanechol
1 of 1
Experimental Treatment
37 Total Participants · 1 Treatment Group
Primary Treatment: Bethanechol · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the projected enrollment for this trial?
"Affirmative. According to details available on clinicaltrials.gov, this trial began recruiting patients as of February 1st 2022 and has been modified since then. Currently, the study requires 37 individuals across a single site to partake in it." - Anonymous Online Contributor
Is enrollment for this study still available?
"As per the clinicaltrials.gov registry, this medical trial is actively searching for participants. It was first published on February 1st 2022 and later updated on March 2nd of the same year." - Anonymous Online Contributor
Has the FDA officially sanctioned Bethanechol for public consumption?
"Due to the lack of efficacy-related data, our analysts assigned bethanechol a safety rating of 2 out of 3." - Anonymous Online Contributor